Skip to main content
. 2018 Dec 11;13(12):e0208922. doi: 10.1371/journal.pone.0208922

Fig 4. Blocking experiments with IFX, F(ab)2 of IFX and ADA in two samples of CD patients with ATI and 2 samples of RA patients with anti-ADA antibodies.

Fig 4

There is no cross reactivity among ATI and anti-ADA and the IFX antibodies are directed against the F(ab)2-fragment of IFX.